143 related articles for article (PubMed ID: 37296274)
1. Targeting miR-126 in Ph+ acute lymphoblastic leukemia.
Qiao J; Zhao D; Nguyen LXT; Chen F; Liang C; Estrella K; Ghoda LY; Heisterkamp N; Marcucci EC; Kuo YH; Marcucci G; Zhang B
Leukemia; 2023 Jul; 37(7):1540-1544. PubMed ID: 37296274
[No Abstract] [Full Text] [Related]
2. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
3. miR-153-3p Suppresses Inhibitor of Growth Protein 2 Expression to Function as Tumor Suppressor in Acute Lymphoblastic Leukemia.
Jiang J; Liu Y; Zhao Y; Tian F; Wang G
Technol Cancer Res Treat; 2019; 18():1533033819852990. PubMed ID: 31138034
[TBL] [Abstract][Full Text] [Related]
4. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.
Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML
Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
6. miR-451a induced apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells by targeting IL-6R.
Jiang T; Chen J; Huang XB; Li YX; Zhong L
Neoplasma; 2018 Nov; 65(6):907-914. PubMed ID: 30334451
[TBL] [Abstract][Full Text] [Related]
7. [Expression of miR-16 in patients with T lymphoblastic lymphoma/acute lymphoblastic leukemia].
Tong LG; Wu WZ; Zhang YP; Zhou ZG; Chen YF; Huang WJ; Xu H; Su QQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):99-103. PubMed ID: 24598659
[TBL] [Abstract][Full Text] [Related]
8. Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment.
Gutierrez-Camino Á; Umerez M; Lopez-Lopez E; Santos-Zorrozua B; Martin-Guerrero I; de Andoin NG; Ana S; Navajas A; Astigarraga I; Garcia-Orad A
Pharmacogenomics; 2018 Dec; 19(18):1403-1412. PubMed ID: 30479191
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Valiollahi E; Ribera JM; Genescà E; Behravan J
Mol Biol Rep; 2019 Feb; 46(1):1295-1306. PubMed ID: 30712246
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
[TBL] [Abstract][Full Text] [Related]
11. Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238.
Liang C; Li Y; Wang LN; Zhang XL; Luo JS; Peng CJ; Tang WY; Huang LB; Tang YL; Luo XQ
Hematology; 2021 Dec; 26(1):16-25. PubMed ID: 33357126
[TBL] [Abstract][Full Text] [Related]
12. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
[TBL] [Abstract][Full Text] [Related]
13. microRNA-181a enhances cell proliferation in acute lymphoblastic leukemia by targeting EGR1.
Verduci L; Azzalin G; Gioiosa S; Carissimi C; Laudadio I; Fulci V; Macino G
Leuk Res; 2015 Apr; 39(4):479-85. PubMed ID: 25740602
[TBL] [Abstract][Full Text] [Related]
14. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of gene copy number, copy neutral LOH, and microRNA profiles in adult acute lymphoblastic leukemia.
Ninomiya S; Tyybäkinoja A; Borze I; Räty R; Saarinen-Pihkala UM; Usvasalo A; Elonen E; Knuutila S
Cytogenet Genome Res; 2012; 136(4):246-55. PubMed ID: 22456238
[TBL] [Abstract][Full Text] [Related]
16. miRNA deregulation in childhood acute lymphoblastic leukemia: a systematic review.
Gutierrez-Camino A; Garcia-Obregon S; Lopez-Lopez E; Astigarraga I; Garcia-Orad A
Epigenomics; 2020 Jan; 12(1):69-80. PubMed ID: 31833405
[TBL] [Abstract][Full Text] [Related]
17. MiR-137 inhibits cell proliferation in acute lymphoblastic leukemia by targeting JARID1B.
Huang Y; Zou Y; Zheng R; Ma X
Eur J Haematol; 2019 Sep; 103(3):215-224. PubMed ID: 31206203
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of microRNA profiling data does not reveal a consensus signature for B cell acute lymphoblastic leukemia.
Longjohn MN; Squires WRB; Christian SL
Gene; 2022 May; 821():146211. PubMed ID: 35134470
[TBL] [Abstract][Full Text] [Related]
19. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation.
Kaddar T; Chien WW; Bertrand Y; Pages MP; Rouault JP; Salles G; Ffrench M; Magaud JP
Leuk Res; 2009 Sep; 33(9):1217-23. PubMed ID: 19195700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]